American Cannabis (AMMJ) Stock Price, News & Analysis

Company Overview

American Cannabis Company, Inc. (OTCMKTS: AMMJ) is a diversified holding and management company focused on the legal cannabis industry. The firm makes strategic equity investments and provides operational support to a network of businesses engaged in the cultivation, extraction, manufacturing, distribution, and retail of cannabis and hemp-derived products.

The company’s portfolio spans the full value chain, from greenhouses and indoor cultivation facilities to processing labs, manufacturing sites and dispensary operations. American Cannabis offers license‐to‐operate services, regulatory compliance oversight, supply chain sourcing and other turn-key business solutions designed to help emerging cannabis brands scale efficiently in both medical and adult‐use markets.

Headquartered in Las Vegas, Nevada, American Cannabis leverages its management expertise to enter key U.S. jurisdictions and select international markets where cannabis regulation has been established. Through strategic partnerships and joint ventures, the company seeks to optimize cultivation capacity, accelerate product innovation—such as vape cartridges, edibles and distillates—and build sustainable branding platforms for long‐term growth.

Key Stats

• Today's Range: $0.0008 to $0.0008
• 50-Day Range: N/A
• 52-Week Range: $0.0001 to $0.01
• Volume: 98,778 shs
• Average Volume: 22,139 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

American Cannabis Stock Analysis - MarketRank™

American Cannabis scored higher than 3% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for American Cannabis.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of American Cannabis is -0.01, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of American Cannabis is -0.01, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Short Interest

• Score: 2.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

American Cannabis has a short interest ratio ("days to cover") of 0.01, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

American Cannabis does not currently pay a dividend.

Dividend Growth

American Cannabis does not have a long track record of dividend growth.

News and Social Media

• Score: 2.3 / 5
• News Sentiment: N/A

News Sentiment

American Cannabis has a news sentiment score of 0.67. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.57 average news sentiment score of Industrials companies.

Company Ownership

• Score: 0.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, American Cannabis insiders have not sold or bought any company stock.

Percentage Held by Insiders

1.04% of the stock of American Cannabis is held by insiders.

Percentage Held by Institutions

American Cannabis has minimal institutional ownership at this time.

Company Calendar

• Last Earnings: 8/21/2017
• Today: 6/11/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Industrials
• Industry: Consulting Services
• Sub-Industry: Cannabis
• Current Symbol: OTCMKTS:AMMJ
• Previous Symbol: NASDAQ:AMMJ
• CIK: 945617
• Web: www.americancannabisconsulting.com
• Phone: +1-303-9744770
• Fax: N/A
• Employees: 20
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A